# An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes

> **NCT04269668** · NA · COMPLETED · sponsor: **Rabin Medical Center** · enrollment: 28 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** Medtronic Minimed 670G 3.0 HCL
- **DEVICE:** Medtronic Minimed 670G 4.0 AHCL

## Key facts

- **NCT ID:** NCT04269668
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-19
- **Primary completion:** 2021-02-20
- **Final completion:** 2021-03-20
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-02-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04269668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04269668, "An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04269668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*